SHENZHEN, SHENZHEN, CHINA, January 20, 2026 /EINPresswire.com/ -- The global shift towards hybrid and remote work ...
Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...
A regulatory setback for Moderna’s next-generation flu vaccine underscores mounting scrutiny of late-stage trial design in the U.S., even as the company pivots to international manufacturing ...
Moderna Inc. MRNA stock fell Wednesday as the company faced a setback following a refusal-to-file letter from the U.S. Food ...
Rezoning decision opens sacred Dan River lands to heavy industry despite community opposition and unresolved cultural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results